semaglutide cardiovascular outcomes news 2025 Improves in Patients With History of Coronary Artery Bypass Graft and Obesity Semaglutide protects the heart beyond

GLP-1 and PCOS: where changes feel strongest Among all groups, women with PCOS reported the most pronounced shifts

What If My GLP-1 Appeal Is Still Denied

For people with diabetes, daily fasting glucose checks with periodic post-meal testing provides useful information

Effect of antioxidant supplementation containing L-carnitine on semen parameters: a prospective interventional study

Retatrutide directly improves glucose regulation through GLP-1-mediated insulin secretion and GIP-mediated glucose-dependent insulin effects

Licensed UK alternatives for weight management include Wegovy (semaglutide 2.4 mg) under NICE TA875, and Mounjaro (tirzepatide) for eligible patients with type 2 diabetes